Teva Pharmaceutical Industries Ltd. Downgraded To #BB# On Continued Challenges To Outlook Stable

Stocks and Financial Services Press Releases Friday February 9, 2018 08:30
NEW YORK--9 Feb--S&P Global Ratings

NEW YORK (S&P Global Ratings) Feb. 8, 2018--S&P Global Ratings today lowered its long-term corporate credit rating on Israel-based Teva Pharmaceutical Industries Ltd. to 'BB' from 'BBB-' and removed the rating from CreditWatch, where we placed with negative implications on Feb. 2, 2018.

The outlook is stable. At the same time, we lowered our issue-level rating on the senior unsecured debt to 'BB' and assigned a '3' recovery rating to this tranche. We removed the issue-level rating from CreditWatch with negative implications.

The '3' recovery rating reflects our expectation for meaningful (50%-70%; rounded estimate 50%) recovery in the event of a payment default. The rating action on Teva reflects a series of lower-than-expected operating results following the 2016 acquisition of Actavis Generics for $33.4 billion in cash and additional equity. We initially believed the acquisition would deliver a material boost to Teva's future generic first-to-market performance, as well as provide a level of scale that would give Teva a competitive advantage over peers like Mylan and Perrigo.

In addition to revising our financial forecasts lower, the successive operating misses led us to lower our expectations for Teva's long-term stability and predictability. Our stable outlook reflects our expectation for substantial revenue declines from Copaxone and U.S. generics in 2018, but that cost cutting and more stable U.S. generics results by 2019 will support gradual deleveraging and still-significant free cash flow generation. We expect free cash flow of about $2.6 billion in 2018 and $2.2 billion in 2019, commensurate with average FFO to debt of about 12% from 2017-2019.


Latest Press Release

KTC invites members to enjoy shopping with worthwhileness and special privileges at Osaka Japan.

Miss Sudchavee Banjobdee, Senior Manager – Credit Card Business, "KTC" or Krungthai Card Public Company Limited,jointly with Miss Tharinee Wongwattanun, Senior Marketing Manager, JCB International (Thailand) Company Limited, invite KTC JCB PLATINUM...

New Accenture Study Forecasts End to #Lucrative Inefficiencies for $1 Trillion Capital Markets Industry as It Adapts to the Digital Age

Wealth and asset managers generate most of the industry's profits but struggle to find scale efficiencies and are highly exposed to squeeze scenarios A new study from Accenture (NYSE: ACN) shows how the capital markets industry can wring out historical...

UMITRON secures US$2 million project funding from the Inter-American Development Bank to deliver IoT and AI technology to drive growth of sustainable aquaculture in Lake Titicaca, Peru

UMITRON PTE.LTD. (Singapore, Co-founder/Managing Director, Masahiko Yamada) in cooperation with Abaco (Cooperativa de Ahorro y Credito) and its subsidiary Piscis (Piscifactorias de los Andes) has been approved for US$2 million project funding to improve...

Photo Release: KBank wins Best Private Bank in Thailand 2018 award on the global stage

Mr. Jirawat Supornpaibul, Private Banking Group Head, recently represented KBank to receive the "Best Private Bank in Thailand 2018" award at the PWM/The Banker Global Private Banking Awards, organized by The Banker Magazine. It is the 24th best private...

Fitch Affirms BAFS at #A+(tha)#; Maintains Negative Outlook

Fitch Ratings (Thailand) Limited has affirmed Bangkok Aviation Fuel Services Public Company Limited's (BAFS) National Long-Term Rating at 'A+(tha)' and maintained Negative Outlook. Fitch has also affirmed BAFS's National Short-Term Rating at...

Related Topics